ZEB1 limits adenoviral infectability by transcriptionally repressing the Coxsackie virus and Adenovirus Receptor

Molecular Cancer

Volumn 10, Issue , 2011, Pages

  Lacher, Markus D ^a,c   Shiina, Marisa ^a   Chang, Peter ^a,d   Keller, Debora ^a,e   Tiirikainen, Maarit I ^a,f   Korn, W Michael ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Swiss Federal Institute of Technology ^*  (United States)

^d DEPARTMENT OF CARDIOLOGY   (Singapore)

^e EPFL   (Switzerland)

^f UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

Adenovirus; Cancer; EMT; MET; TGF ; ZEB1

Indexed keywords

COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; FIBRONECTIN; PROTEIN ZEB1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UVOMORULIN; VIRUS PROTEIN; CXADR LIKE MEMBRANE PROTEIN; CXADR-LIKE MEMBRANE PROTEIN; HOMEODOMAIN PROTEIN; TRANSCRIPTION FACTOR; VIRUS RECEPTOR; ZEB1 PROTEIN, HUMAN;

ADENOVIRUS INFECTION; ARTICLE; CANCER CELL; CELL STIMULATION; CHROMATIN; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; MESENCHYME CELL; PHENOTYPE; PROTEIN BINDING; PROTEIN EXPRESSION; ADENOVIRUS; EPITHELIAL MESENCHYMAL TRANSITION; EVALUATION; FEMALE; GENE EXPRESSION REGULATION; GENE VECTOR; GENETICS; HORIZONTAL GENE TRANSFER; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; SEQUENCE HOMOLOGY; TUMOR CELL LINE;

ADENOVIRIDAE; COXSACKIEVIRUS; GASTROPODA;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; BASE SEQUENCE; CELL LINE, TUMOR; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION; GENE TRANSFER, HORIZONTAL; GENETIC VECTORS; HOMEODOMAIN PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; RECEPTORS, VIRUS; SEQUENCE HOMOLOGY, NUCLEIC ACID; TRANSCRIPTION FACTORS;

EID: 79960682928     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-10-91     Document Type: Article

References (56)

1. Excoffon KJ, Gansemer ND, Mobily ME, Karp PH, Parekh KR, Zabner J. Isoform-specific regulation and localization of the coxsackie and adenovirus receptor in human airway epithelia. PloS one 2010, 5:e9909. 10.1371/journal.pone.0009909, 2845650, 20361046.
2. Lisewski U, Shi Y, Wrackmeyer U, Fischer R, Chen C, Schirdewan A, Juttner R, Rathjen F, Poller W, Radke MH, Gotthardt M. The tight junction protein CAR regulates cardiac conduction and cell-cell communication. The Journal of experimental medicine 2008, 205:2369-2379. 10.1084/jem.20080897, 2556793, 18794341.
3. Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997, 275:1320-1323. 10.1126/science.275.5304.1320, 9036860.
4. Korn WM, Macal M, Christian C, Lacher MD, McMillan A, Rauen KA, Warren RS, Ferrell L. Expression of the coxsackievirus- and adenovirus receptor in gastrointestinal cancer correlates with tumor differentiation. Cancer Gene Ther 2006, 13:792-797. 10.1038/sj.cgt.7700947, 16628228.
5. Anders M, Christian C, McMahon M, McCormick F, Korn WM. Inhibition of the Raf/MEK/ERK pathway up-regulates expression of the coxsackievirus and adenovirus receptor in cancer cells. Cancer Res 2003, 63:2088-2095.
6. Goldsmith ME, Kitazono M, Fok P, Aikou T, Bates S, Fojo T. The histone deacetylase inhibitor FK228 preferentially enhances adenovirus transgene expression in malignant cells. Clin Cancer Res 2003, 9:5394-5401.
7. Hoti N, Chowdhury W, Hsieh JT, Sachs MD, Lupold SE, Rodriguez R. Valproic acid, a histone deacetylase inhibitor, is an antagonist for oncolytic adenoviral gene therapy. Mol Ther 2006, 14:768-778. 10.1016/j.ymthe.2006.07.009, 16990052.
8. Kuster K, Koschel A, Rohwer N, Fischer A, Wiedenmann B, Anders M. Downregulation of the coxsackie and adenovirus receptor in cancer cells by hypoxia depends on HIF-1alpha. Cancer Gene Ther 2010, 17:141-146. 10.1038/cgt.2009.49, 19590529.
9. Lacher MD, Tiirikainen MI, Saunier EF, Christian C, Anders M, Oft M, Balmain A, Akhurst RJ, Korn WM. Transforming growth factor-beta receptor inhibition enhances adenoviral infectability of carcinoma cells via up-regulation of Coxsackie and Adenovirus Receptor in conjunction with reversal of epithelial-mesenchymal transition. Cancer Res 2006, 66:1648-1657. 10.1158/0008-5472.CAN-05-2328, 16452224.
10. Pong RC, Lai YJ, Chen H, Okegawa T, Frenkel E, Sagalowsky A, Hsieh JT. Epigenetic regulation of coxsackie and adenovirus receptor (CAR) gene promoter in urogenital cancer cells. Cancer Res 2003, 63:8680-8686.
11. Shiina M, Lacher MD, Christian C, Korn WM. RNA interference-mediated knockdown of p21(WAF1) enhances anti-tumor cell activity of oncolytic adenoviruses. Cancer Gene Ther 2009,
12. Lacher MD, Korn WM, Akhurst RJ. Transforming Growth Factor-beta in Cancer Therapy. Volume II. Chapter 43. Reversal of EMT by Small-Molecule Inhibitors of TGF-beta Type I and II Receptors: Implications for Carcinoma Treatment 2008, Totowa, New Jersey: Humana Press.
13. Kang Y, Massague J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 2004, 118:277-279. 10.1016/j.cell.2004.07.011, 15294153.
14. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A, Weinberg RA. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004, 117:927-939. 10.1016/j.cell.2004.06.006, 15210113.
15. Jorda M, Olmeda D, Vinyals A, Valero E, Cubillo E, Llorens A, Cano A, Fabra A. Upregulation of MMP-9 in MDCK epithelial cell line in response to expression of the Snail transcription factor. J Cell Sci 2005, 118:3371-3385. 10.1242/jcs.02465, 16079281.
16. Akhurst RJ, Balmain A. Genetic events and the role of TGF beta in epithelial tumour progression. J Pathol 1999, 187:82-90. 10.1002/(SICI)1096-9896(199901)187:1<82::AID-PATH248>3.0.CO;2-8, 10341708.
17. Cui W, Fowlis DJ, Bryson S, Duffie E, Ireland H, Balmain A, Akhurst RJ. TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 1996, 86:531-542. 10.1016/S0092-8674(00)80127-0, 8752208.
18. Haddow S, Fowlis DJ, Parkinson K, Akhurst RJ, Balmain A. Loss of growth control by TGF-beta occurs at a late stage of mouse skin carcinogenesis and is independent of ras gene activation. Oncogene 1991, 6:1465-1470.
19. Iyer S, Wang ZG, Akhtari M, Zhao W, Seth P. Targeting TGFbeta signaling for cancer therapy. Cancer Biol Ther 2005, 4:261-266. 10.4161/cbt.4.3.1566, 15846079.
20. Massague J. TGFbeta in Cancer. Cell 2008, 134:215-230. 10.1016/j.cell.2008.07.001, 18662538.
21. Massague J, Gomis RR. The logic of TGFbeta signaling. FEBS Lett 2006, 580:2811-2820. 10.1016/j.febslet.2006.04.033, 16678165.
22. Siegel PM, Massague J. Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer 2003, 3:807-821. 10.1038/nrc1208, 14557817.
23. Vandewalle C, Comijn J, De Craene B, Vermassen P, Bruyneel E, Andersen H, Tulchinsky E, Van Roy F, Berx G. SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions. Nucleic Acids Res 2005, 33:6566-6578. 10.1093/nar/gki965, 1298926, 16314317.
24. De Craene B, Gilbert B, Stove C, Bruyneel E, van Roy F, Berx G. The transcription factor snail induces tumor cell invasion through modulation of the epithelial cell differentiation program. Cancer Res 2005, 65:6237-6244. 10.1158/0008-5472.CAN-04-3545, 16024625.
25. Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?. Nat Rev Cancer 2007, 7:415-428. 10.1038/nrc2131, 17508028.
26. Bracken CP, Gregory PA, Kolesnikoff N, Bert AG, Wang J, Shannon MF, Goodall GJ. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res 2008, 68:7846-7854. 10.1158/0008-5472.CAN-08-1942, 18829540.
27. Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna S, Brabletz T. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep 2008, 9:582-589. 10.1038/embor.2008.74, 2396950, 18483486.
28. Yu J, Ohuchida K, Mizumoto K, Sato N, Kayashima T, Fujita H, Nakata K, Tanaka M. MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation. Mol Cancer 2010, 9:169. 10.1186/1476-4598-9-169, 2909980, 20579395.
29. Martin TA, Goyal A, Watkins G, Jiang WG. Expression of the transcription factors snail, slug, and twist and their clinical significance in human breast cancer. Ann Surg Oncol 2005, 12:488-496. 10.1245/ASO.2005.04.010, 15864483.
30. Rosivatz E, Becker I, Specht K, Fricke E, Luber B, Busch R, Hofler H, Becker KF. Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer. Am J Pathol 2002, 161:1881-1891. 10.1016/S0002-9440(10)64464-1, 1850763, 12414534.
31. Singh M, Spoelstra NS, Jean A, Howe E, Torkko KC, Clark HR, Darling DS, Shroyer KR, Horwitz KB, Broaddus RR, Richer JK. ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive disease. Mod Pathol 2008, 21:912-923. 10.1038/modpathol.2008.82, 18487993.
32. Spoelstra NS, Manning NG, Higashi Y, Darling D, Singh M, Shroyer KR, Broaddus RR, Horwitz KB, Richer JK. The transcription factor ZEB1 is aberrantly expressed in aggressive uterine cancers. Cancer Res 2006, 66:3893-3902. 10.1158/0008-5472.CAN-05-2881, 16585218.
33. Remacle JE, Kraft H, Lerchner W, Wuytens G, Collart C, Verschueren K, Smith JC, Huylebroeck D. New mode of DNA binding of multi-zinc finger transcription factors: deltaEF1 family members bind with two hands to two target sites. Embo J 1999, 18:5073-5084. 10.1093/emboj/18.18.5073, 1171578, 10487759.
34. Aigner K, Dampier B, Descovich L, Mikula M, Sultan A, Schreiber M, Mikulits W, Brabletz T, Strand D, Obrist P, et al. The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity. Oncogene 2007, 26:6979-6988. 10.1038/sj.onc.1210508, 2899859, 17486063.
35. Shirakihara T, Saitoh M, Miyazono K. Differential regulation of epithelial and mesenchymal markers by deltaEF1 proteins in epithelial mesenchymal transition induced by TGF-beta. Mol Biol Cell 2007, 18:3533-3544. 10.1091/mbc.E07-03-0249, 1951739, 17615296.
36. Grooteclaes ML, Frisch SM. Evidence for a function of CtBP in epithelial gene regulation and anoikis. Oncogene 2000, 19:3823-3828. 10.1038/sj.onc.1203721, 10949939.
37. Vincent T, Neve EP, Johnson JR, Kukalev A, Rojo F, Albanell J, Pietras K, Virtanen I, Philipson L, Leopold PL, et al. A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-beta mediated epithelial-mesenchymal transition. Nat Cell Biol 2009, 11:943-950. 10.1038/ncb1905, 19597490.
38. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994, 22:4673-4680. 10.1093/nar/22.22.4673, 308517, 7984417.
39. Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E, Mareel M, Huylebroeck D, van Roy F. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 2001, 7:1267-1278. 10.1016/S1097-2765(01)00260-X, 11430829.
40. Matys V, Kel-Margoulis OV, Fricke E, Liebich I, Land S, Barre-Dirrie A, Reuter I, Chekmenev D, Krull M, Hornischer K, et al. TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes. Nucleic Acids Res 2006, 34:D108-110. 10.1093/nar/gkj143, 1347505, 16381825.
41. Benbrook DM, Jones NC. Different binding specificities and transactivation of variant CRE's by CREB complexes. Nucleic Acids Res 1994, 22:1463-1469. 10.1093/nar/22.8.1463, 308006, 8190638.
42. Paca-Uccaralertkun S, Zhao LJ, Adya N, Cross JV, Cullen BR, Boros IM, Giam CZ. In vitro selection of DNA elements highly responsive to the human T-cell lymphotropic virus type I transcriptional activator, Tax. Mol Cell Biol 1994, 14:456-462. 358395, 8264613.
43. Kim J, You L, Xu Z, Kuchenbecker K, Raz D, He B, Jablons D. Wnt inhibitory factor inhibits lung cancer cell growth. J Thorac Cardiovasc Surg 2007, 133:733-737. 10.1016/j.jtcvs.2006.09.053, 17320573.
44. Ginzinger DG. Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream. Exp Hematol 2002, 30:503-512. 10.1016/S0301-472X(02)00806-8, 12063017.
45. Hata A, Seoane J, Lagna G, Montalvo E, Hemmati-Brivanlou A, Massague J. OAZ uses distinct DNA- and protein-binding zinc fingers in separate BMP-Smad and Olf signaling pathways. Cell 2000, 100:229-240. 10.1016/S0092-8674(00)81561-5, 10660046.
46. Ginzinger DG, Godfrey TE, Nigro J, Moore DH, Suzuki S, Pallavicini MG, Gray JW, Jensen RH. Measurement of DNA copy number at microsatellite loci using quantitative PCR analysis. Cancer Res 2000, 60:5405-5409.
47. Bowles KR, Gibson J, Wu J, Shaffer LG, Towbin JA, Bowles NE. Genomic organization and chromosomal localization of the human Coxsackievirus B-adenovirus receptor gene. Hum Genet 1999, 105:354-359. 10.1007/s004390051114, 10543405.
48. Buckland PR. The importance and identification of regulatory polymorphisms and their mechanisms of action. Biochim Biophys Acta 2006, 1762:17-28.
49. Quandt K, Frech K, Karas H, Wingender E, Werner T. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic acids research 1995, 23:4878-4884. 10.1093/nar/23.23.4878, 307478, 8532532.
50. Ellenrieder V, Hendler SF, Boeck W, Seufferlein T, Menke A, Ruhland C, Adler G, Gress TM. Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation. Cancer Res 2001, 61:4222-4228.
51. Ui-Tei K, Naito Y, Nishi K, Juni A, Saigo K. Thermodynamic stability and Watson-Crick base pairing in the seed duplex are major determinants of the efficiency of the siRNA-based off-target effect. Nucleic acids research 2008, 36:7100-7109. 10.1093/nar/gkn902, 2602766, 18988625.
52. Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL, Arteaga CL. Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem 2000, 275:36803-36810. 10.1074/jbc.M005912200, 10969078.
53. Xie L, Law BK, Aakre ME, Edgerton M, Shyr Y, Bhowmick NA, Moses HL. Transforming growth factor beta-regulated gene expression in a mouse mammary gland epithelial cell line. Breast Cancer Res 2003, 5:R187-198. 10.1186/bcr640, 314403, 14580254.
54. Sanchez-Tillo E, Lazaro A, Torrent R, Cuatrecasas M, Vaquero EC, Castells A, Engel P, Postigo A. ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1. Oncogene 2010, 29:3490-3500. 10.1038/onc.2010.102, 20418909.
55. Haque I, Mehta S, Majumder M, Dhar K, De A, McGregor D, Van Veldhuizen PJ, Banerjee SK, Banerjee S. Cyr61/CCN1 signaling is critical for epithelial-mesenchymal transition and stemness and promotes pancreatic carcinogenesis. Molecular cancer 2011, 10:8. 10.1186/1476-4598-10-8, 3027193, 21232118.
56. Chen JW, Ghosh R, Finberg RW, Bergelson JM. Structure and chromosomal localization of the murine coxsackievirus and adenovirus receptor gene. DNA and cell biology 2003, 22:253-259. 10.1089/104454903321908647, 12823902.